{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:13:08Z","timestamp":1792883588430,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1-R21AR068477-01"],"award-info":[{"award-number":["1-R21AR068477-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16J40231"],"award-info":[{"award-number":["16J40231"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["363"],"award-info":[{"award-number":["363"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA14051"],"award-info":[{"award-number":["P30-CA14051"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004043","name":"Kanazawa Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001642","name":"Glenn Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002160","name":"Jain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016872","name":"Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016872","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.isci.2021.103667","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T11:57:34Z","timestamp":1640001454000},"page":"103667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["4-Phenylbutyrate restores localization and membrane repair to human dysferlin mutations"],"prefix":"10.1016","volume":"25","author":[{"given":"Kana","family":"Tominaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoomi","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric O.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rufibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Sch\u00f6wel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Spuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard P.","family":"Guarente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2021.103667_bib1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bpj.2013.11.4492","article-title":"Quantitation of the calcium and membrane binding properties of the C2 domains of dysferlin","volume":"106","author":"Abdullah","year":"2014","journal-title":"Biophys. J."},{"key":"10.1016\/j.isci.2021.103667_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tcb.2004.03.001","article-title":"Dysferlin and the plasma membrane repair in muscular dystrophy","volume":"14","author":"Bansal","year":"2004","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.isci.2021.103667_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature01573","article-title":"Defective membrane repair in dysferlin-deficient muscular dystrophy","volume":"423","author":"Bansal","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.isci.2021.103667_bib4","series-title":"Dysferlin in Skeletal and Heart Muscle: From Trafficking to Therapy","author":"Bersch","year":"2017"},{"key":"10.1016\/j.isci.2021.103667_bib5","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ejhg.2011.70","article-title":"Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations","volume":"19","author":"Cacciottolo","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.isci.2021.103667_bib6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/hmg\/ddy013","article-title":"Repairing folding-defective \u03b1-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D","volume":"27","author":"Carotti","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.isci.2021.103667_bib7","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3390\/ijms21051813","article-title":"Combined use of CFTR correctors in LGMD2D myotubes improves sarcoglycan complex recovery","volume":"21","author":"Carotti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2021.103667_bib8","doi-asserted-by":"crossref","first-page":"14147","DOI":"10.1074\/jbc.M112.448589","article-title":"Dysferlin regulates cell adhesion in human monocytes","volume":"288","author":"de Morree","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2021.103667_bib9","doi-asserted-by":"crossref","first-page":"28529","DOI":"10.1074\/jbc.M110.111120","article-title":"Reduced plasma membrane expression of dysferlin mutants is attributed to accelerated endocytosis via a syntaxin-4-associated pathway","volume":"285","author":"Evesson","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2021.103667_bib10","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/mus.25367","article-title":"Progress and challenges in diagnosis of dysferlinopathy","volume":"54","author":"Fanin","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.isci.2021.103667_bib11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/hmg\/ddm002","article-title":"Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin\/proteasome ERAD(I) and autophagy\/lysosome ERAD(II)","volume":"16","author":"Fujita","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.isci.2021.103667_bib12","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXG.0000000000000089","article-title":"The clinical outcome study for dysferlinopathy an international multicenter study","volume":"2","author":"Harris","year":"2016","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.isci.2021.103667_bib13","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1194\/jlr.M090845","article-title":"Dysferlin deficiency alters lipid metabolism and remodels the skeletal muscle lipidome in mice","volume":"60","author":"Haynes","year":"2019","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2021.103667_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.yexcr.2011.10.004","article-title":"GREG cells, a dysferlin-deficient myogenic mouse cell line","volume":"318","author":"Humphrey","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.isci.2021.103667_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0","article-title":"Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype","volume":"49","author":"Illa","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.isci.2021.103667_bib16","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/WNL.55.12.1931","article-title":"Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy","volume":"55","author":"Illarioshkin","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2021.103667_bib17","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.4103\/0366-6999.190671","article-title":"Dysferlin gene mutation spectrum in a large cohort of Chinese patients with dysferlinopathy","volume":"129","author":"Jin","year":"2016","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.isci.2021.103667_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/sb500322u","article-title":"Enhanced MyoD-induced transdifferentiation to a myogenic lineage by fusion to a potent transactivation domain","volume":"4","author":"Kabadi","year":"2015","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.isci.2021.103667_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fphys.2014.00089","article-title":"Dysferlin at transverse tubules regulates Ca(2+) homeostasis in skeletal muscle","volume":"5","author":"Kerr","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.isci.2021.103667_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.biocel.2015.01.015","article-title":"The therapeutic effects of 4-phenylbutyric acid in maintaining proteostasis","volume":"61","author":"Kolb","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.isci.2021.103667_bib21","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.1038\/ncomms14659","article-title":"A chemical chaperone improves muscle function in mice with a RyR1 mutation","volume":"8","author":"Lee","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2021.103667_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1471-2148-10-231","article-title":"Phylogenetic analysis of ferlin genes reveals ancient eukaryotic origins","volume":"10","author":"Lek","year":"2010","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.isci.2021.103667_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0854.2011.01267.x","article-title":"Ferlins: regulators of vesicle fusion for auditory neurotransmission, receptor trafficking and membrane repair","volume":"13","author":"Lek","year":"2012","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"10.1016\/j.isci.2021.103667_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/1682","article-title":"Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy","volume":"20","author":"Liu","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2021.103667_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cbi.2015.09.025","article-title":"4-PBA prevents pressure overload-induced myocardial hypertrophy and interstitial fibrosis by attenuating endoplasmic reticulum stress","volume":"242","author":"Luo","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.isci.2021.103667_bib26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.omtn.2018.08.013","article-title":"Exon skipping in a Dysf-missense mutant mouse model","volume":"13","author":"Malcher","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.isci.2021.103667_bib27","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1016\/j.bmcl.2013.08.001","article-title":"4-Phenylbutyric acid protects against neuronal cell death by primarily acting as a chemical chaperone rather than histone deacetylase inhibitor","volume":"23","author":"Mimori","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.isci.2021.103667_bib28","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jvs.2010.06.172","article-title":"Sodium 4-phenylbutyrate protects against spinal cord ischemia by inhibition of endoplasmic reticulum stress","volume":"52","author":"Mizukami","year":"2010","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.isci.2021.103667_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/humu.9355","article-title":"Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies","volume":"26","author":"Nguyen","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.isci.2021.103667_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2021.103667_bib31","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1172\/JCI24898","article-title":"Small-molecule correctors of defective \u0394F508- CFTR cellular processing identified by high- throughput screening Find the latest version: small-molecule correctors of defective \u0394 F508-CFTR cellular processing identified by high-throughput screening","volume":"115","author":"Pedemonte","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2021.103667_bib32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1164\/ajrccm.157.2.9706088","article-title":"A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in \u03b4F508-Homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function","volume":"157","author":"Rubenstein","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.isci.2021.103667_bib33","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1172\/JCI119788","article-title":"In\u00a0vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing \u0394F08-CFTR","volume":"100","author":"Rubenstein","year":"1997","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2021.103667_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2021.103667_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0049603","article-title":"Dysferlin-peptides reallocate mutated dysferlin thereby restoring function","volume":"7","author":"Schoewel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2021.103667_bib36","doi-asserted-by":"crossref","first-page":"101232","DOI":"10.1016\/j.redox.2019.101232","article-title":"Targeting ER stress\/ER stress response in myopathies","volume":"26","author":"Zito","year":"2019","journal-title":"Redox Biol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004221016370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004221016370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T19:28:35Z","timestamp":1762630115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004221016370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2589004221016370"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2021.103667","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-Phenylbutyrate restores localization and membrane repair to human dysferlin mutations","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2021.103667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"103667"}}